ClinicalTrials.gg
CompletedNCT02801825AxFemArtUpdated Dec 21, 2021

Ultrasound-guided Axillary Artery vs Femoral Artery Cannulation.

An interventional study of Real-time ultrasound-guided in-plane infraclavicular axillary artery cannulation. and Real-time ultrasound-guided out-of-plane femoral artery cannulation. in Critical Illness, sponsored by Uniwersytecki Szpital Kliniczny w Opolu. Completed at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-21.

Sponsored by Uniwersytecki Szpital Kliniczny w Opolu · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The main purpose of the study is to compare two ultrasound-guided arterial cannulation procedures: in-plane infraclavicular axillary artery cannulation and out-of-plane femoral artery cannulation.

02

Conditions studied

  • Critical Illness

Browse trials for

Keywords

  • axillay artery
  • cannulation
  • femoral artery
03

In context

Critical Illness

1,787 studies on the registry are indexed under Critical Illness; 445 are open to participants now.

This study's enrollment of 110 is above the median of 90 across 930 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Uniwersytecki Szpital Kliniczny w Opolu is the lead sponsor of 11 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

mechanically ventilated critically ill patients with indications for artery cannulation:

  • in whom radial artery cannulation is unable to perform or
  • in order to conduct hemodynamic monitoring using transpulmonary thermodilution

Exclusion criteria

Exclusion Criteria:

  • age less than 18 years
  • trauma and hematoma at the catheterization site
  • coagulation disorders
  • infection at the catheterization site
  • lack of patients or closest relatives contents
  • precedent surgery operation into the femoral and axillary arteries
  • clinically significant ischemia of the limb at the cannulation side
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
110 participants (actual)

Study arms

  • Experimental
    Axillary artery.

    Cannulation of the axillary artery.

    Procedure: Real-time ultrasound-guided in-plane infraclavicular axillary artery cannulation.

  • Experimental
    Femoral artery.

    Cannulation of the femoral artery.

    Procedure: Real-time ultrasound-guided out-of-plane femoral artery cannulation.

Interventions

  • ProcedureReal-time ultrasound-guided in-plane infraclavicular axillary artery cannulation.

    Real-time ultrasound-guided in-plane infraclavicular axillary artery cannulation.

  • ProcedureReal-time ultrasound-guided out-of-plane femoral artery cannulation.

    Real-time ultrasound-guided out-of-plane femoral artery cannulation.

06

What researchers measure

Primary outcomes

  1. Cannulation success rate

    The goal of the assessment of the cannulation success rate is essential for the estimation of the usefulness of both artery approaches in clinical practice.

    Time frame: 24 hours

Secondary outcomes

  1. Procedure complication rate.

    The goal of the assessment of the early mechanical complication rate is crucial for the estimation of the safety of both procedures in clinical practice.

    Time frame: 24 hours

  2. Number of puncture attempts.

    The goal of the assessment is the evaluation which approach is easier to perform.

    Time frame: 24 hours

07

Study locations

1 site
  • Department of Anesthesiology and Intensive Care, Uniwersytecki Szpital Kliniczny w Opolu
    Opole, 45-401, Poland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2018 to primary completion in Oct 2020, 32 months.

Of 405 non-industry interventional studies with no phase under Critical Illness, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's 32 months is above that.

Counting every sponsor, half of 409 studies reached it within 21 months; a quarter within 11 and three quarters within 40.

Critical Illness covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 7, 2016
First posted
Jun 16, 2016
StartActual
Jan 22, 2018
Primary completionActual
Oct 1, 2020
CompletionActual
Aug 1, 2021
Last update
Dec 21, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 21, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02801825
Lead sponsor
Uniwersytecki Szpital Kliniczny w Opolu
Responsible party
Ryszard Gawda, MD PhD (Ryszard Gawda, MD PhD, Uniwersytecki Szpital Kliniczny w Opolu) — Principal investigator
First posted
Jun 16, 2016
Start date
Jan 22, 2018
Primary completion
Oct 1, 2020
Completion
Aug 1, 2021
Last update
Dec 21, 2021

Study contacts

Ryszard Gawda, MD PhD
principal investigator · Department of Anesthesiology and Intensive Care, Uniwersytecki Szpital Kliniczny w Opolu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion